摘要
完善的中成药说明书【注意事项】不仅是医师选药用药的重要参考,还能为药师开展用药咨询、用药教育、用药监护、用药重整、处方审核等全程药学服务提供有力证据,以保障患者合理用药,降低用药风险。由《上市中成药说明书安全信息项目修订技术规范注意事项》(T/CACM 1370.4-2021)团体标准引发思考,通过梳理上市中成药说明书【注意事项】,发现存在【注意事项】缺如、对临床用药提示不足等问题。结合专家访谈及问卷调研结果,以影响用药安全的药物因素、患者因素及临床用药因素3个角度为切入点,建立基于中成药说明书【注意事项】完善的临床药学服务策略,即以“贯穿药品使用全过程,遵循中医药理论”为原则,以实施药学服务的主体为对象,依托中成药说明书【注意事项】内容,提出不同药学服务项目的实施路径,形成【注意事项】药学服务内容,达到提升药学服务水平、促进临床合理用药的目的。
A complete set of precautions in Chinese patent medicine(CPM) instructions is an important reference for physicians to select and use medicines. It also provides solid support for pharmacists to provide comprehensive pharmaceutical care, including counseling and monitoring of drug use, medication education, medication reconciliation, prescription review, and other activities that can help patients use medications safely and sensibly. By researching the item of precautions in CPM instructions and taking into account the association standard of Technical Specifications for Revision of Safety Information in Marketed Chinese Patent Medicine Instructions-Precautions(T/CACM 1370.4-2021), it was found that there were problems such as a lack of precautions and limited implications for the clinical use of medications. By combining the result of expert interviews and questionnaires, this paper presented the strategies for clinical pharmaceutical care based on the improvement of precautions in CPM instructions from three factors affecting medication safety, including medicines, patients, and clinical use of medications. The strategies follow the principle of “adopting traditional Chinese medicine theories throughout the entire process”, take the subjects of pharmaceutical care as the objects, and suggest various routes for implementing different pharmaceutical services based on the precautions in CPM instructions to create the contents of pharmaceutical care. Establishing strategies for clinical pharmaceutical care based on improving precautions in CPM instructions could enhance pharmaceutical services and promote rational use of medications.
作者
萨日娜
张晓朦
张冰
林志健
徐慧哲
SA Ri'na;ZHANG Xiaomeng;ZHANG Bing;LIN Zhijian;XU Huizhe(School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 102488,China;Center for Pharmacovigilance and Rational Use of Chinese Medicine,Bejing University of Chinese Medicine,Beijing 102488,China;Gansu Provincial Hospital,Lanzhou 730000,China)
出处
《北京中医药大学学报》
CAS
CSCD
北大核心
2022年第10期994-998,共5页
Journal of Beijing University of Traditional Chinese Medicine
基金
国家中医药管理局中医药创新团队及人才支持计划子项目(No.ZYYCXTD-C-202005-11)
国家中医药领军人才支持计划“岐黄学者”项目(No.国中医药人教函2018-248号)。
关键词
中成药说明书
注意事项
药学服务
Chinese patent medicine instructions
precautions
pharmaceutical care
